ABSTRACT
connected via an array of rounded pillars to form a permeable micro-membrane. One channel acts as a vascular compartment and is coated by a fully confluent monolayer of endothelial cells, whereas the other channel is filled with a mixture of matrigel and breast cancer cells (MDA-MB-231) and reproduces the malignant tissue. The vascular permeability can be finely modulated by inducing pro-inflammatory conditions in the tissue compartment, which transiently opens up the tight junctions of endothelial cells. Permeability ranges from 1 m/sec (tight endothelium) to 5 m/sec (TNF- at 50 ng/mL overnight) and up to  10 m/sec (no endothelium). Fresh medium flowing continuously in the vascular compartment is sufficient to induce cancer cell intravasation at rates of 8 cells/day with an average velocity of  0.5 m/min. On the other hand, the vascular adhesion and extravasation of circulating cancer cells require TNF- stimulation. Extravasation occurs at lower rates with 4 cells/day and an average velocity of  0.1 m/min. Finally, the same chip is completely filled with matrigel and the migration of cancer cells from one channel to the other is monitored over a region of about 400 m. Invasion rates of 12 cells/day are documented upon TNF- stimulation. This work demonstrates that the proposed compartmentalized microfluidic chip can efficiently replicate in vitro, under controlled biophysical and biochemical conditions, the multiple key steps in the cancer metastatic cascade.
INTRODUCTION
It is well accepted that metastases and disease recurrence are the main causes of death in cancer patients. 1 The ability of malignant cells to enter the blood stream, abandoning the primary tumor mass; disseminate through the vascular network, searching for a new homing tissue; adhere to the vascular walls, resisting hemodynamic forces; extravasate at a distant site, opening the endothelial barrier; and, eventually, migrate away from the blood vessels, infiltrating a new tissue; is crucial in the formation of metastatic niches. [2] [3] [4] This stepwise sequence of events is regulated by a multitude of biophysical and biochemical processes, including alterations of cell polarity, cytoskeletal and nuclear architecture, and expression of membrane receptors. For instance, the intravasation of tumor cells is supported by the well-known epithelial-to-mesenchymal transition (EMT), which involves the disruption of intercellular adhesion, cell polarity and the overexpression of specific cell-matrix adhesion molecules. 5, 6 Inside the vascular network, tumor cells, which are then called circulating mechanisms are yet to be fully elucidated, establishing metastatic niches is not a random process but is affected by the local microenvironment, vascular architecture as well as by the type and location of the original malignant mass. [7] [8] [9] [10] [11] Different microscopy techniques, including conventional confocal fluorescent microscopy and intravital video microscopy, have been employed to monitor the fate of individual cancer cells and the progressive formation of metastatic niches. In this context, non-mammalian model organisms, such as zebrafishes and drosophilas, and small rodents, such as mice and rats, have been used to recapitulate the metastatic evolution of different tumor types. 12, 13 19 , pancreas 20 and prostate. 21 Protocols have been also developed to image the formation and evolution of clusters of CTCs. 22 Although animal models offer a more authentic representation of the key biophysical and biochemical features regulating cancer metastases, it is difficult to control, accurately and independently, the many governing parameters. For this reason, systematic analyses on the temporal and spatial evolution of CTCs can be more efficiently performed solely using in vitro assays.
Cell migration across biological barriers has been traditionally studied using a Boyden chamber assay, which was originally employed for mimicking leukocyte chemotaxis and, then, applied to study tumor cell invasion. 23 In this system, a porous membrane separates two different compartments, which contain the cells and media of interest. Despite its simplicity, the Boyden chamber assay does not allow one to monitor in real time cell migration from one chamber to the other, given the difference in focal planes; and, more importantly, cannot support fluid flow, which affects cell dynamics, cytoskeletal architecture and receptor expression. In order to address these limitations, microfluidic-based assays have been developed over the last few years with diverse applications. For instance, cell infiltration was studied by Chaw and colleagues, who fabricated a 5 multi-step microfluidic device where cells are forced to squeeze within tiny and long orifices filled with extracellular matrices. 24 A similar approach was also employed by others to study cancer cell migration under chemical gradients and electric fields. 25 The group of Roger Kamm realized a microfluidic platform comprising a central and two lateral channels, separated by an intermediate chamber, to study cancer cell migration, invasion and extravasation. [26] [27] [28] [29] Other groups mostly focused on CTC adhesion to endothelial cells under flow, upon stimulation by specific chemokines and pro-inflammatory molecules. 30, 31 Yet, an experimental set-up for reproducing the multiple, key events in the metastatic cascade is missing.
In this work, a compartmentalized microfluidic device is proposed, which comprises two microchannels running in parallel and connected by a micro-membrane realized in the lateral walls ( Figure.1 ). Differently from a Boyden chamber, the device allows one to monitor simultaneously the dynamics of cells within the two different compartments and across the micro-membrane. This is microfabricated to include a series of pillars forming openings smaller than 3 m, which separate the two channels into two different compartments. Endothelial cells are deposited in the vascular compartment forming a confluent layer over the micro-membrane, whereas an extracellular matrix enriched with different cell types is deposited within the tissue compartment. The device can be used for studying cell intravasation, vascular transport and adhesion, extravasation and invasion, thus helping to address key steps in the complex metastatic cascade.
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MATERIAL AND METHODS
Fabrication of the double microfluidic chip. The fabrication of the microfluidic chip device involved two lithographic steps, as detailed in the sequel. Following protocols previously detailed by the authors 32 , the chip was obtained using a top-down fabrication approach.
Two optical masks, one negative for the two parallel channels and one positive for the micropillars membrane, were realized using a laser writing machine (DLW6000). The AZ5214E (Microchem) photoresist was employed due to its capability to work both in negative and positive processes. It was spin-coated at 4,000 rpm on a Cr surface, then the resulting sample was baked a 110 ˚C for 60 s to clean the resist. The mask including the micromembrane was impressed using a mask-aligner on the resist at 80 mJ. The solvent AZ726MF (Microchem) was used as a developer for the resist. The impressed pattern was transferred from the resist to the Cr mask by using a commercial Cr etchant (Chrome etch 18, OSC OrganoSpezialChemie GmbH). The residual resist layer was then removed from the unexposed surface via acetone cleansing and sonication. An ICP-RIE Bosh process (Si 500, Sentech Instruments GmbH) was performed to transfer the micropillar membrane over the Si, etching down by 5 µm. In the Bosh process, each cycle consists of a deposited phase and an etching phase. The obtained Si wafer with the impressed micromembrane was used then for transferring the channels. The fabrication method was the same used for the pillars except for the resist, which was here used in reversal mode (i.e. negative mode). AZ5214E was spin-coated on the residual Cr layer and baked at 110˚C for 60 s. After a realignment phase between the channels mask on the micromembrane, the photoresist was exposed at 95 mJ. Since the resist was used in reversal mode, the wafer required an additional baking phase at 120˚C for 120 s and an exposure phase at 300 mJ.
Then, developing was performed as for the micromembrane. At this point, both pillars and channels are impressed on the Cr layer, whereas the pillars only are on the Si wafer. A second ICP-RIE Bosh etching was performed down to 50 µm, which is the actual height of the channels.
Then, both pillars and channels were transferred on the Si layer. Before replicating this geometry on a polydimethylsiloxane (PDMS) layer, an anti-stiction film of 1H,1H,2H,2H-Perfluoro-octyl- Permeability experiments in the microfluidic chip. Microfluidic chips were autoclaved at 120 °C for sterilization. Then they were dried to remove the water from channels and placed in an incubator overnight (37 °C, humidity > 95%). Matrigel 8-12 mg/mL (Sigma Aldrich) was maintained in ice, then it was mixed with Eagle's minimum essential medium (EMEM) (ATCC © , USA) to yield a final matrix concentration of 4-6 mg/mL. 50 ng/mL of TNF-α were introduced in the matrigel, while on ice to prevent gelation. This allowed the homogeneous dispersion of TNF-α in a still liquid matrigel solution. Then, the liquid mix of matrigel with 50 ng/mL TNF-α was introduced in the 
RESULTS
The compartmentalized microfluidic device. A custom designed polydimethylsiloxane (PDMS) microfluidic device was used to reproduce the key steps in the metastatic process. The device consists of two parallel channels divided by a permeable membrane of rounded pillars ( Figure.1) .
The channels present a total length of 2.7 cm (from inlet to outlet), a height of 50 µm and a width of 210 µm. The equivalent hydraulic diameter of the channels is comparable in size to large capillaries, arterioles and venules. The permeable membrane is placed in the center of the channels and is 500 µm long. The separation distance between the two channels, across the pillar membrane, is equal to ̴ 3 µm, which is sufficient to compartmentalize the two channels while still allowing molecules and cells to diffuse through. Therefore, the two compartments can be independently filled at the occurrence with different matrices (collagen, matrigel, hyaluronic acid, and combinations thereof) and cells (endothelial, cancer, stromal, immune cells and so on). In Figure. 1a, a schematic of the microfluidic devices is presented together with electron microscopy images revealing the details of the micro-membrane. Specifically, the first electron micrograph shows the central portion of the device with the arrays of pillars constituting the micro-membrane.
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The second electron micrograph returns the shape and separation distance between adjacent pillars within the micro-membrane. These are slender structures, with an aspect ratio larger than 2.5, presenting a rounded shape to enhance lateral mechanical stability. In Figure. other authors. 34 The chart in Figure. 2b gives the permeability values as well as the formula employed to extract these values from the experimental data. Indeed, these results demonstrate the ability to modulate the vascular permeability in the device by properly stimulating confluent endothelial cells. Permeability experiments were also conducted at lower flow rates, namely 50 nL/min (Supporting Figure.3) . Importantly, only a minor difference in permeability was observed for the two different flow rates. Figure.4 ), the transport of breast cancer cells (MDA-MB-231) across the endothelialized micro-membrane into the vascular compartment was considered. Tumor cells were mixed with matrigel and infused into the extravascular compartment, whereas endothelial cells were seeded and cultured in the vascular channel. During the whole experiment, cell culture medium was continuously infused on the vascular side with a flow rate of Q = 50 nL/min, which is typical for microvascular flow. 35 Despite the high density of matrigel, the fresh medium and nutrients in the vascular channel were sufficient to attract cancer cells. Intravasation events were observed over time and were only accounted for when the whole cell body was found in the vascular compartment. (Table S1 ). Permeability studies in a compartmentalized microfluidic device Nuclei are stained in blue with DAPI, F-Actin is stained in green with phalloidin.
Modeling the intravasation of cancer cells. After assessing the vascular permeability of the device under different flows conditions and TNF-α stimulations (Supporting
